HDAC9 and embryonal carcinoma: HDAC inhibitors, including VPA, have been shown to alter Hox gene expression in mouse embryos, ES cells [26] and human embryonal carcinoma cells [27] and can increase levels of H3 acetylation at Hoxb1 control elements in mouse ES cells [28].